Key Developments: HCA Holdings Inc (HCA)

HCA on New York Consolidated

37.53USD
24 May 2013
Price Change (% chg)

$-0.37 (-0.98%)
Prev Close
$37.90
Open
$37.71
Day's High
$37.84
Day's Low
$37.38
Volume
1,453,292
Avg. Vol
4,197,246
52-wk High
$41.83
52-wk Low
$23.91

Search Stocks

Latest Key Developments (Source: Significant Developments)

HCA Holdings Inc Reaffirms FY 2013 Guidance
Thursday, 2 May 2013 08:31am EDT 

HCA Holdings Inc reaffirmed its previously issued guidance ranges for fiscal 2013. According to I/B/E/S Estimates, analysts were expecting the Company to report EBITDA of $6.35 billion and EPS of $3.13 for fiscal 2013.  Full Article

HCA Holdings Inc Issues Q1 2013 Guidance; Reaffirms FY 2013 Guidance
Monday, 15 Apr 2013 04:30pm EDT 

HCA Holdings Inc announced that for the first quarter of 2013, it expects revenues to be approximately $8.440 billion. Income before income taxes is expected to approximate $639 million. Adjusted EBITDA is expected to be approximately $1.568 billion compared and adjusted EBITDA is a non-GAAP financial measure. The Company also reaffirming its previously issued guidance ranges for fiscal 2013.  Full Article

HCA Holdings Inc Announces Secondary Offering
Monday, 11 Feb 2013 04:15pm EST 

HCA Holdings Inc announced that certain of its stockholders, consisting principally of affiliates of, or funds sponsored by, Bain Capital Partners, LLC and Kohlberg Kravis Roberts & Co. (the Selling Stockholders), intend to offer for sale in an underwritten at-the-market secondary offering approximately 50 million shares of its common stock pursuant to the Company's shelf registration statement filed with the Securities and Exchange Commission. The Selling Stockholders will receive all of the proceeds from this offering. No shares are being sold by management or the Company. The last reported sale price of the Company's common stock on February 8, 2013 was $37.22 per share. The offering is expected to close on February 15, 2013, subject to customary closing conditions. Barclays Capital Inc. and Citigroup Global Markets Inc. will act as underwriters for the offering.  Full Article

HCA Holdings Inc Issues FY 2013 Guidance; EBITDA And EPS Guidance Below Analysts' Estimates
Tuesday, 5 Feb 2013 08:29am EST 

HCA Holdings Inc announced that for fiscal 2013, it expects revenue in the range of $33.50-$34.50 billion, adjusted EBITDA in the range of $6.25-$6.50 billion, adjusted EPS (diluted) in the range of $3.00-$3.30. This guidance range excludes the impact of items, if applicable, that are non-operational in nature including items such as, but not limited to, gains or losses on sales of facilities and businesses, gains or losses on early debt retirement and impairments of long-lived assets. The guidance includes estimated EHR incentive income assumptions in a range of $200-$225 million and EHR expenses in a range of $110-$130 million. According to I/B/E/S Estimates, analysts were expecting the Company to report EBITDA of $6.53 billion and EPS of $3.46 for fiscal 2013.  Full Article

HCA Holdings Inc Announces Special Dividend Of $2.00 Per Share
Thursday, 6 Dec 2012 04:47pm EST 

HCA Holdings Inc announced that its Board of Directors has approved a special cash dividend of $2.00 per share to be paid to shareholders of record as of December 17, 2012 with a payment date of December 21, 2012.  Full Article

HCA Holdings Inc Announces Proposed Public Offering Of $1.0 Billion Senior Notes
Monday, 3 Dec 2012 07:15am EST 

HCA Holdings Inc announced that it proposes to offer, subject to market and other considerations, $1.0 billion aggregate principal amount of senior notes. Actual terms of the notes, including interest rate and principal amount, will depend on market conditions at the time of pricing. HCA intends to use the net proceeds of this offering to make a distribution to its stockholders and certain optionholders and to pay related fees and expenses. Citigroup, Barclays, BofA Merrill Lynch, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, SunTrust Robinson Humphrey and Wells Fargo Securities are acting as the joint book-running managers for the offering.  Full Article

HCA Holdings Inc Announces Intention To Declare Special Cash Dividend Of $2.00 per Share
Monday, 3 Dec 2012 07:13am EST 

HCA Holdings Inc announced that it intends to declare and pay a special cash dividend of $2.00 per share to stockholders and certain optionholders on or prior to December 31, 2012.  Full Article

HCA Holdings Inc Announces Proposed Public Offering of $2 Billion Senior Notes
Tuesday, 16 Oct 2012 08:55am EDT 

HCA Holdings Inc's HCA Inc. announced that it proposes to offer, subject to market and other considerations, $2 billion aggregate principal amount of senior secured notes and senior unsecured notes. Actual terms of the notes, including interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds of this offering for general corporate purposes, which may include the repayment of its existing term loan B-1 facility, due November, 2013 and the financing of a dividend to stockholders of HCA Holdings, Inc. BofA Merrill Lynch, Barclays, Citigroup, Deutsche Bank Securities, Goldman, Sachs & Co., J.P. Morgan and Wells Fargo Securitiesare acting as the joint book-running managers for the offering.  Full Article

HCA Holdings Inc Issues Q3 2012 Guidance
Tuesday, 16 Oct 2012 08:53am EDT 

HCA Holdings Inc announced that for the third quarter of 2012, it expects revenues to be approximate $8.062 billion, net income to be approximately $360 million, earnings per diluted share (EPS) to be $0.78 and adjusted EBITDA to be approximate $1.533 billion.  Full Article

Ryan & Maniskas, LLP Announces Investigation Of HCA Holdings Inc.
Thursday, 9 Aug 2012 05:28pm EDT 

Ryan & Maniskas, LLP announced that it is investigating potential claims against the board of directors of HCA Holdings Inc. (HCA or the Company) concerning possible breaches of fiduciary duty and other violations of law related to the U.S. Department of Justice (DOJ) investigation into the Company’s billing practices. On August 6, 2012, HCA stated it is currently under investigation by the DOJ in relation to its billing practices and the medical necessity of heart procedures performed at hospitals operated by the Company. Also on August 6, 2012, The New York Times published a report citing evidence that some of the Company’s hospitals performed needless angioplasties and stents surgeries on patients for the sole purpose of boosting profits for the Company.  Full Article

HCA issues first-quarter estimates, shares fall

- HCA Holdings Inc , the largest U.S. for-profit hospital operator, on Monday announced a preliminary first-quarter revenue estimate that was below Wall Street expectations and its shares fell nearly 5 percent.

Search Stocks